Ownership history in Man Group plc · 8 quarters on record
This page tracks every 13F SEC filing in which Man Group plc reported a position in SUMMIT THERAPEUTICS INC (SMMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 29,550 | -10,857 | -26.9% | 0.00% | $611K | $20.66 |
| 2025 Q2 | ADDED | 40,407 | +21,402 | +112.6% | 0.00% | $860K | $21.28 |
| 2025 Q1 | ADDED | 19,005 | +2,330 | +14.0% | 0.00% | $367K | $19.29 |
| 2024 Q4 | ADDED | 16,675 | +5,065 | +43.6% | 0.00% | $298K | $17.84 |
| 2024 Q3 | REDUCED | 11,610 | -71,006 | -85.9% | 0.00% | $254K | $21.90 |
| 2023 Q1 | ADDED | 82,616 | +59,524 | +257.8% | 0.00% | $145K | $1.75 |
| 2022 Q4 | ADDED | 23,092 | +7,373 | +46.9% | 0.00% | $98K | $4.25 |
| 2022 Q3 | INITIATED | 15,719 | — | — | 0.00% | $19K | $1.19 |
As of 2025 Q4 — sorted by position size